The biopharmaceutical market in South East Asia was valued at US$ 18.4 billion in 2023. It is anticipated to grow at a CAGR of 8.25% during 2024-2032, reaching approximately US$ 37.6 billion by 2032. https://www.imarcgroup.com/south-east-asia-biopharmaceutical-market